A 52-Week, Multinational, Multi-Centre, Open-Labelled Extension Trial of Insulin Detemir in Children and Adolescents 3-17 Years With Type 1 Diabetes on a Basal-Bolus Regimen With Insulin Aspart as Bolus Insulin
Latest Information Update: 05 Oct 2021
At a glance
- Drugs Insulin detemir (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 01 Dec 2016 Results published in the Diabetes Therapy
- 29 Nov 2016 New trial record